Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254